Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist

Open access

Abstract

Salvia divinorum , whose main active ingredient is the neoclerodane diterpene Salvinorin A, is a hallucinogenic plant in the mint family that has been used in traditional spiritual practices for its psychoactive properties by the Mazatecs of Oaxaca, Mexico. More recently, S. divinorum extracts and Salvinorin A have become more widely used in the U.S. as legal hallucinogens. We discovered that Salvinorin A potently and selectively inhibited 3 H-bremazocine binding to cloned κ opioid receptors. Salvinorin A had no significant activity against a battery of 50 receptors, transporters, and ion channels and showed a distinctive profile compared with the prototypic hallucinogen lysergic acid diethylamide. Functional studies demonstrated that Salvinorin A is a potent κ opioid agonist at cloned κ opioid receptors expressed in human embryonic kidney-293 cells and at native κ opioid receptors expressed in guinea pig brain. Importantly, Salvinorin A had no actions at the 5-HT 2A serotonin receptor, the principal molecular target responsible for the actions of classical hallucinogens. Salvinorin A thus represents, to our knowledge, the first naturally occurring nonnitrogenous opioid-receptor subtype-selective agonist. Because Salvinorin A is a psychotomimetic selective for κ opioid receptors, κ opioid-selective antagonists may represent novel psychotherapeutic compounds for diseases manifested by perceptual distortions (e.g., schizophrenia, dementia, and bipolar disorders). Additionally, these results suggest that κ opioid receptors play a prominent role in the modulation of human perception.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.182234399

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 50 references

Research works printed but not linked: 3

  1. B L Roth, E Palvimaki, S Berry, N Khan, N Sachs, A Uluer, M Choudhary J Pharmacol Exp Ther 275, 1638–1646 (1995).
  2. M S Choudhary, N Sachs, A Uluer, R A Glennon, R B Westkaemper, B L Roth Mol Pharmacol 47, 450–457 (1995).
  3. W R Martin, C G Eades, J A Thompson, R E Huppler, P E Gilbert J Pharmacol Exp Ther 197, 517–532 (1976).

Cited by

See all 784

Metadata

Authors
Roth, B. L., Baner, K., Westkaemper, R., Siebert, D., Rice, K. C., Steinberg, S., Ernsberger, P., & Rothman, R. B.
Affiliations
National Institutes of Health (US)
Venue
Proceedings of the National Academy of Sciences
Published
2002-08-21
Volume
99
Issue
18
Pages
11934-11939
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2005643237
Cited by
784
References
50
Citations by year
2026: 20 · 2025: 26 · 2024: 27 · 2023: 25 · 2022: 30 · 2021: 33 · 2020: 25 · 2019: 37 · 2018: 30 · 2017: 44 · 2016: 45 · 2015: 29 · 2014: 39 · 2013: 42 · 2012: 42
FWCI
18.87
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (n01mh080004-000)
  • National Institute of Mental Health (KO2MH01366, K02MH001366, N01 MH080004, N02MH80004)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Alkaloids: synthesis and pharmacology
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Keywords
salvinorin A, Salvia divinorum, kappa opioid receptor, kappa opioid receptor agonists, hallucinogens, lysergic acid diethylamide, 5-HT2A receptor, psychotomimetics
MeSH terms
Animals, Brain, Diterpenes, Guinea Pigs, Models, Molecular, Radioligand Assay, Recombinant Proteins, Receptors, Opioid, kappa, Salvia, Diterpenes, Clerodane, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist. https://app.cochat.ai/papers/10.1073/pnas.182234399
The paper
Roth, B. L., Baner, K., Westkaemper, R., Siebert, D., Rice, K. C., Steinberg, S., Ernsberger, P., & Rothman, R. B. (2002). Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.182234399

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.